Riding My Harley Through Cancer: Christy’s Stage 4 Lung Cancer Story
From riding her Harley to competing in strongman events, Christy’s journey shows how hope and targeted therapy can make life after diagnosis possible.
When Christy Erickson was diagnosed with stage IV lung cancer at just 41, she feared she wouldn’t see her children grow up. After months of unanswered questions and second opinions, genetic testing showed her tumor had an EGFR mutation. That result opened the door to a targeted therapy called osimertinib. The treatment gave her more time with her family and the chance to live fully, not just survive.
A Turning Point: Genetic Testing and Targeted Therapy
Genetic testing revealed that Christy Erickson’s lung cancer carried an EGFR mutation, making her eligible for osimertinib—a targeted therapy supported by years of clinical research. Although she wasn’t enrolled in the pivotal trial, she directly benefited from the breakthroughs that helped make the treatment widely available. Osimertinib (brand name Tagrisso) is an oral targeted therapy (an EGFR inhibitor) used for certain types of non-small cell lung cancer (NSCLC) with EGFR mutations (such as exon 19 deletions or L858R). It works by blocking overactive epidermal growth factor receptors (EGFR), which can help slow or stop cancer cell growth; common side effects may include diarrhea, skin changes, and low blood counts.
(Source: Winship Cancer Institute of Emory University)
Read the complete article here >
Stay Connected with Stage 4 Hope
Hear more stories like Christy’s—riding her Harley after being diagnosed with stage IV lung cancer at just 41, daring to dream and continuing to live on her terms—and other late-stage lung cancer stories from people living with cancer. Discover information on treatments, clinical trials, symptom management, and real stories from others on the same journey. Join our community to stay informed with the latest research updates, upcoming retreats, and educational events.
References:
1. https://www.cancerresearchuk.org/about-cancer/treatment/drugs/osimertinib
